At NIBGO INNO PHARMCHEM CO.,LTD., we are dedicated to providing the building blocks for advanced healthcare solutions. Ursodeoxycholic Acid (CAS 128-13-2) is a prime example of a compound whose biochemical properties translate into significant therapeutic benefits, particularly for liver health.

Ursodeoxycholic Acid, often abbreviated as UDCA, is a secondary bile acid naturally produced in the body. However, its therapeutic administration, especially in cases of liver disease, enhances its natural functions. The Ursodeoxycholic Acid treatment of liver disease is multifaceted. It is a primary treatment for Primary Biliary Cirrhosis (PBC), an autoimmune condition where bile ducts in the liver are damaged. UDCA helps to improve bile flow, reduce cholestasis, and protect liver cells from damage, thereby slowing disease progression.

The mechanism by which UDCA benefits the liver involves several key actions. It can be incorporated into bile acid pools, replacing more toxic hydrophobic bile acids with less toxic hydrophilic ones. This change in bile composition reduces the cytotoxic effect on liver cells. Additionally, UDCA has been shown to have immunomodulatory and anti-inflammatory effects, further contributing to liver protection. This makes it invaluable not only for PBC but also for other cholestatic conditions and potentially for managing complications of other liver diseases.

While widely known for Ursodeoxycholic Acid for gallstone dissolution and its role in Ursodeoxycholic Acid prevention of gallstones, its impact on the liver itself is equally significant. By improving bile flow and reducing the toxic burden on hepatocytes, it directly supports overall liver function and health.

As a leading high purity Ursodeoxycholic Acid supplier, NIBGO INNO PHARMCHEM CO.,LTD. ensures that every batch of our CAS 128-13-2 product meets the highest pharmaceutical standards. This commitment is crucial for a compound used in delicate medical treatments. When you choose to buy Ursodeoxycholic Acid powder from us, you are assured of its quality and suitability for critical pharmaceutical formulations.

The precise CAS 128-13-2 chemical properties of Ursodeoxycholic Acid, including its molecular structure and purity levels, are meticulously controlled. This attention to detail guarantees that healthcare providers receive a reliable and effective product for treating a range of liver ailments.

In conclusion, Ursodeoxycholic Acid is a cornerstone of modern hepatology. NIBGO INNO PHARMCHEM CO.,LTD. is proud to contribute to advancements in liver treatment by supplying this essential, high-quality pharmaceutical intermediate.